LHALA shot Q image. (photo = GC Green Cross Wellbeing)
GC Green Cross Wellbeing announced on the 9th that it will start selling LHALA Shot Q by signing a domestic distribution contract with H2MEDI.
With this contract, the two companies will not only expand domestic sales of LHALA shot Q, but also establish close partnerships and make efforts to promote LHALA shot Q products, including attending domestic and international conferences and marketing including seminars.
LHALA shot Q is a new concept solution that uses DDS (Drug Delivery System, Niosom). The company explained that it is effective in reducing sebum secretion and alleviating inflammation by maximizing laser effect.
Kim Sang-hyun, CEO of GC Green Cross Wellbeing, said, "We are happy to be able to distribute LHALA shot Q products together with the excellent technology of H2MEDI. The two companies will work together to expand the base of LHALA shot Q, and make LHALA shot Q play a new role in the acne treatment and skincare market."
LHALA shot Q image. (photo = GC Green Cross Wellbeing)
GC Green Cross Wellbeing announced on the 9th that it will start selling LHALA Shot Q by signing a domestic distribution contract with H2MEDI.
With this contract, the two companies will not only expand domestic sales of LHALA shot Q, but also establish close partnerships and make efforts to promote LHALA shot Q products, including attending domestic and international conferences and marketing including seminars.
LHALA shot Q is a new concept solution that uses DDS (Drug Delivery System, Niosom). The company explained that it is effective in reducing sebum secretion and alleviating inflammation by maximizing laser effect.
Kim Sang-hyun, CEO of GC Green Cross Wellbeing, said, "We are happy to be able to distribute LHALA shot Q products together with the excellent technology of H2MEDI. The two companies will work together to expand the base of LHALA shot Q, and make LHALA shot Q play a new role in the acne treatment and skincare market."